#Dantrolene

Dantrolene is a ryanodine (RYR1) receptor antagonist, which prevents release of Ca<sup>2+</sup> from the sarcoplasmic reticulum, uncoupling the excitation-contraction process.

|Property|Dantrolene|
|--|--|
|**Uses**|MH, NMS, ecstasy intoxication, chronic muscle spasticity
|**Presentation**|Vials of orange powder containing 20mg dantrolene and 3g mannitol, reconstituted with 60ml of H<sub>2</sub>O to form an alkaline solution.
|**Dosing**|2.5mg.kg<sup>-1</sup> IV every 10-15 minutes, up to 10mg.kg<sup>-1</sup>. Once resolved, continue giving 1mg.kg<sup>-1</sup> every 4-6 hours for 24 hours.
|**Absorption**| IV only, may cause skin necrosis if extravasates.
|**Distribution**|85% protein bound
|**Metabolism**|Hepatic metabolism to active 5-hydroxy-dantrolene
|**Elimination**|Renal of metabolites, t<sub>1/2</sub>Î² of 12 hours
|**Resp**|Respiratory failure due to skeletal muscle weakness
|**CVS**|Volume overload due to large volume given with administration
|**MSK**|Skeletal muscle relaxation
|**Renal**|Diuresis
|**GIT**|Hepatic failure

---

##References
Peck and Hill
Petkov
ANZCA August/September 2011